100%(1)1 out of 1 people found this document helpful
This preview shows page 1 - 4 out of 6 pages.
Running Header: Teva PharmaceuticalsTeva Pharmaceuticals, LtdWeek 3 – Case Study Response
Running Header: Teva PharmaceuticalsAbstractTeva pharmaceutical is one of the largest generic pharmaceutical manufacturers in the world today. This industry giant can trace its roots back to the early 1900’s as Salomon, Levine and Elstein (SLE). Growth through acquisition, international expansion and competitive advantage can all be linked to Teva’s tremendous success over the years, but this may not be enough to drive them into the future. This paper will evaluate the current status of the company and its resources, how they may be able to capitalize on innovation and whether they still maintain a competitive advantage in the market. It will also present options available to Teva for potential market expansion and way forward.Keywords: Pharmaceutical, Generic
Running Header: Teva PharmaceuticalsTeva Pharmaceuticals, LtdWeek 3 – Case Study ResponseSince the 1970’s numerous global companies have emerged that are based out of what is now called Israel. This small peninsula of land houses a country with limited resources and hostile neighbors. Because of this situation many Israeli citizens chose to focus on specialized careers that supported high tech industries. As listed by NASDAQ (NASDAQ, 2014) five out of the ten largest companies in Israel are dedicated to creating electronics. Two are advanced chemical corporations who deal with highly specialized equipment and require highly trained employees to keep sustain them. The largest company in Israel, by a factor of almost 4x is Teva